帕金森病的发病原因
Huw R Morris1, Maria Grazia Spillantini2, Carolyn M Sue3
1Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK; University College London Movement Disorders Centre, University College London, London, UK; Aligning Science Across Parkinson's Collaborative Research Network, Chevy Chase, MD, USA.
Lancet (London, England)
|January 20, 2024
概括
帕金森病涉及α-同核素的聚合和扩散,影响细胞功能和免疫反应. 研究为开发神经保护疗法提供了基础,
科学领域:
- 神经科学
- 病理学
- 遗传学
背景情况:
- 帕金森病是一种进展性神经退行性疾病,其特征是聚合的α-synuclein.
- 了解它的病变包括遗传学,分子病理学和细胞机制.
研究的目的:
- 审查目前对帕金森病发病的见解.
- 根据细胞和分子发现探索潜在的治疗策略.
主要方法:
- 对遗传学和分子病理学研究的审查.
- 生物化学研究,移植神经元研究和细胞/动物模型的分析.
- 检查细胞功能 (线粒体,溶酶体,内体) 和免疫反应.
主要成果:
- 异常的α-synuclein聚合及其扩散 (肠-大脑轴) 与疾病的发展有关.
- 在遗传和零星形式中观察到细胞功能障碍 (线粒体,溶解体,内分体).
- 免疫和炎症反应可能由肠道引发,加速帕金森病的发生.
结论:
- 目前的研究为开发神经保护疗法提供了基础.
- 目的是阻止帕金森病的进展.
- 目前还没有改变疾病的治疗方法, 但合理的治疗方法的发展是有希望的.
相关概念视频
Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K


